Wegrzyn A, Szalewska-Pałasz A, Błaszczak A, Liberek K, Wegrzyn G
Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Laboratory of Molecular Biology affiliated with the University of Gdańsk.
FEBS Lett. 1998 Nov 27;440(1-2):172-4. doi: 10.1016/s0014-5793(98)01449-5.
Rifampicin is an antibiotic which binds to the beta subunit of prokaryotic RNA polymerases and prevents initiation of transcription. It was found previously that production of heat shock proteins in Escherichia coli cells after a shift from 30 degrees C to 43 degrees C is not completely inhibited by this antibiotic. Here we demonstrate that while activity of a pL-lacZ fusion (pL is a sigma70-dependent promoter) in E. coli cells is strongly inhibited by rifampicin, a p(groE)-lacZ fusion, whose activity is dependent on the sigam32 factor, retains significant residual activity even at relatively high rifampicin concentrations. Differential sensitivity to this antibiotic of RNA polymerase holoenzymes containing either the sigma70 or the sigma32 subunit was confirmed in vitro. Since the effects of an antibiotic that binds to the beta subunit can be modulated by the presence of either the sigma70 or the sigma32 subunit in the holoenzyme, it is tempting to speculate that binding of various sigma factors to the core of RNA polymerase results in different conformations of particular holoenzymes, including changes in the core enzyme.
利福平是一种抗生素,它与原核生物RNA聚合酶的β亚基结合,阻止转录起始。先前发现,大肠杆菌细胞从30℃转移到43℃后,热休克蛋白的产生并未被这种抗生素完全抑制。在此我们证明,虽然大肠杆菌细胞中pL-lacZ融合体(pL是一种依赖σ70的启动子)的活性被利福平强烈抑制,但活性依赖于σ32因子的p(groE)-lacZ融合体即使在相对高的利福平浓度下仍保留显著的残余活性。在体外证实了含有σ70或σ32亚基的RNA聚合酶全酶对这种抗生素的敏感性差异。由于结合到β亚基的抗生素的作用可通过全酶中σ70或σ32亚基的存在而调节,因此很容易推测各种σ因子与RNA聚合酶核心的结合会导致特定全酶的不同构象,包括核心酶的变化。